Subtype

Malignant Female Reproductive System Neoplasm

1,462 active trials11 approved drugs128 evidence items

NCIt: C4913
DOID: 120

Clinical trials

Registered studies

6,252 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,462
Recruiting: 819
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

No study matches these filters